Filing Details
- Accession Number:
- 0001209191-21-051298
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-12 21:25:57
- Reporting Period:
- 2021-08-10
- Accepted Time:
- 2021-08-12 21:25:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1832038 | Adagio Therapeutics Inc. | ADGI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1211060 | Peter Thiel | C/O Mithril Capital Management Llc 600 Congress Avenue Suite 3100 Austin TX 78701 | No | No | Yes | No | |
| 1669609 | Mithril Ii Lp | C/O Mithril Capital Management Llc 600 Congress Avenue Suite 3100 Austin TX 78701 | No | No | Yes | No | |
| 1878230 | Mithril Ii Ugp Llc | C/O Mithril Capital Management Llc 600 Congress Avenue Suite 3100 Austin TX 78701 | No | No | Yes | No | |
| 1878232 | Mithril Ii Gp Lp | C/O Mithril Capital Management Llc 600 Congress Avenue Suite 3100 Austin TX 78701 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-10 | 9,244,580 | $0.00 | 9,244,580 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2021-08-10 | 1,997,000 | $17.00 | 11,241,580 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2021-08-10 | 1,250,000 | $0.00 | 6,250,000 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2021-08-10 | 176,304 | $0.00 | 881,520 | $0.00 |
| Common Stock | Series C Preferred Stock | Disposition | 2021-08-10 | 422,612 | $0.00 | 2,113,060 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock automatically converted, without payment of additional consideration, into 5 shares of Common Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock and had no expiration date.
- These shares are held of record by Mithril II LP ("II LP"). Mithril II UGP LLC ("UGP II") is the general partner of Mithril II GP LP ("GP II") and GP II is the general partner of II LP. Ajay Royan ("Royan"), a member of the Issuer's board of directors, is the sole managing member of UGP II and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by II LP. Peter Thiel ("Thiel") and Royan are the members of the investment committee of GP II. The investment committee makes all investment decisions with respect to shares held by II LP and may be deemed to have shared voting, investment and dispositive power with respect to such shares. Each of UGP II, GP II, Thiel and Royan disclaims beneficial ownership of the shares held by II LP, except to the extent of their respective pecuniary interests therein, if any.
Billionaire Hedge Funds
